Nervafil Tablet

Indication: Painful neurologic manifestations e.g. neuritis, polyneuritis, neuralgia lumbago, ischalgia, sciatica, cervical and shoulder am syndrome, rheumatic pains, herpes zoster, encephalopathies. Neuropathies caused by certain states, e.g. Diabetes and cardiac disorders. Alcoholic neuropathy; latrogenic complications arising from Isoniazid, reserpine and phenothiazine therapy; other drug induced neuropathies. Hyperemesis gravidarum; neuropathic changes during pregnancy. FDA Reg. No.: DRP-1458-02